Slingshot Biosciences, Inc. — Form D/A

Slingshot Biosciences, Inc. of EMERYVILLE, CA, a company, filed a Form D amendment with the SEC on 2021-07-23. The offering totals $22.9M, of which $22.9M was reported sold. Industry: Other.

Offering

• Filed: 2021-07-23
• Form: D/A
• Accession: 0001867067-21-000002
• Industry: Other
• Exemptions: 06b
• Total offering: $22.9M
• Amount sold: $22.9M
• Investors: 17
• Date of first sale: 2021-05-28
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-402858

Issuer

• Name: Slingshot Biosciences, Inc.
• CIK: 0001867067
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 1250 45TH STREET, SUITE 330, EMERYVILLE, CA, 94608
• Phone: (510) 770-6806

Officers, directors & promoters (8)

Other filings by this issuer (3)

More

• CIK 1867067 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search